BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38786780)

  • 1. A Review for Uncovering the "Protein-Nanoparticle Alliance": Implications of the Protein Corona for Biomedical Applications.
    Önal Acet B; Gül D; Stauber RH; Odabaşı M; Acet Ö
    Nanomaterials (Basel); 2024 May; 14(10):. PubMed ID: 38786780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences.
    Foroozandeh P; Aziz AA
    Nanoscale Res Lett; 2015; 10():221. PubMed ID: 25995715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An In Situ Investigation of the Protein Corona Formation Kinetics of Single Nanomedicine Carriers by Self-Regulated Electrochemiluminescence Microscopy.
    Xing Z; Gou X; Jiang LP; Zhu JJ; Ma C
    Angew Chem Int Ed Engl; 2023 Sep; 62(39):e202308950. PubMed ID: 37553293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
    Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
    Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle protein corona evolution: from biological impact to biomarker discovery.
    Kamaly N; Farokhzad OC; Corbo C
    Nanoscale; 2022 Feb; 14(5):1606-1620. PubMed ID: 35076049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the Chemical Nature of Nanoparticle-Protein Interactions.
    Baimanov D; Cai R; Chen C
    Bioconjug Chem; 2019 Jul; 30(7):1923-1937. PubMed ID: 31259537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of surface chemistry and morphology of nanoparticles on protein corona formation.
    Bilardo R; Traldi F; Vdovchenko A; Resmini M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1788. PubMed ID: 35257495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein bio-corona: critical issue in immune nanotoxicology.
    Neagu M; Piperigkou Z; Karamanou K; Engin AB; Docea AO; Constantin C; Negrei C; Nikitovic D; Tsatsakis A
    Arch Toxicol; 2017 Mar; 91(3):1031-1048. PubMed ID: 27438349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering a Nano/Biointerface for Cell and Organ-Selective Drug Delivery.
    Song D; Xu Q
    Langmuir; 2022 Aug; 38(30):9092-9098. PubMed ID: 35852946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disentangling Biomolecular Corona Interactions With Cell Receptors and Implications for Targeting of Nanomedicines.
    Aliyandi A; Zuhorn IS; Salvati A
    Front Bioeng Biotechnol; 2020; 8():599454. PubMed ID: 33363128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic Understanding of Protein Corona Formation around Nanoparticles: Old Puzzles and New Insights.
    Nienhaus K; Nienhaus GU
    Small; 2023 Jul; 19(28):e2301663. PubMed ID: 37010040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold nanoparticle should understand protein corona for being a clinical nanomaterial.
    Charbgoo F; Nejabat M; Abnous K; Soltani F; Taghdisi SM; Alibolandi M; Thomas Shier W; Steele TWJ; Ramezani M
    J Control Release; 2018 Feb; 272():39-53. PubMed ID: 29305922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct observation of a single nanoparticle-ubiquitin corona formation.
    Ding F; Radic S; Chen R; Chen P; Geitner NK; Brown JM; Ke PC
    Nanoscale; 2013 Oct; 5(19):9162-9. PubMed ID: 23921560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging well-tailored nanoparticulate delivery system based on in situ regulation of the protein corona.
    Li Z; Wang Y; Zhu J; Zhang Y; Zhang W; Zhou M; Luo C; Li Z; Cai B; Gui S; He Z; Sun J
    J Control Release; 2020 Apr; 320():1-18. PubMed ID: 31931050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview of Nanoparticle Protein Corona Literature.
    Hajipour MJ; Safavi-Sohi R; Sharifi S; Mahmoud N; Ashkarran AA; Voke E; Serpooshan V; Ramezankhani M; Milani AS; Landry MP; Mahmoudi M
    Small; 2023 Sep; 19(36):e2301838. PubMed ID: 37119440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of protein corona on Graphene Oxide: implications for biomedical theranostics.
    Quagliarini E; Pozzi D; Cardarelli F; Caracciolo G
    J Nanobiotechnology; 2023 Aug; 21(1):267. PubMed ID: 37568181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.
    Wang Y; Cai R; Chen C
    Acc Chem Res; 2019 Jun; 52(6):1507-1518. PubMed ID: 31149804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.
    Barbero F; Russo L; Vitali M; Piella J; Salvo I; Borrajo ML; Busquets-Fité M; Grandori R; Bastús NG; Casals E; Puntes V
    Semin Immunol; 2017 Dec; 34():52-60. PubMed ID: 29066063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.